| Authors: |
Tkaczyk C; AstraZeneca, Early Vaccines & Immune Therapies, Gaithersburg, MD 20878, USA. Electronic address: christine.tkaczyk@astrazeneca.com., Newton M; AstraZeneca, BioPharmaceutical Development, BioPharmaceuticals R&D, Gaithersburg, MD 20878, USA., Patnaik MM; AstraZeneca, Early Vaccines & Immune Therapies, Gaithersburg, MD 20878, USA., Thom G; AstraZeneca, Discovery Sciences, BioPharmaceuticals R&D, Cambridge CB21 6GH, UK., Strain M; AstraZeneca, Biologics Engineering, BioPharmaceuticals R&D, Cambridge CB216GH, UK., Gamson A; AstraZeneca, Early Vaccines & Immune Therapies, Gaithersburg, MD 20878, USA., Daramola O; AstraZeneca, BioPharmaceutical Development, BioPharmaceuticals R&D, Cambridge CB21 6GH, UK., Murthy A; AstraZeneca, BioPharmaceutical Development, BioPharmaceuticals R&D, Cambridge CB21 6GH, UK., Douthwaite J; AstraZeneca, Discovery Sciences, BioPharmaceuticals R&D, Cambridge CB21 6GH, UK., Stepanov O; Clinical Pharmacology and Pharmacometrics, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK., Boger E; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respirator & immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Yang H; Clinical Pharmacology and Pharmacometrics, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Esser MT; AstraZeneca, Early Vaccines & Immune Therapies, Gaithersburg, MD 20878, USA., Lidwell A; AstraZeneca, Early Vaccines & Immune Therapies, Gaithersburg, MD 20878, USA., DiGiandomenico A; AstraZeneca, Early Vaccines & Immune Therapies, Gaithersburg, MD 20878, USA., Santos L; AstraZeneca, BioPharmaceutical Development, BioPharmaceuticals R&D, Gaithersburg, MD 20878, USA., Sellman BR; AstraZeneca, Early Vaccines & Immune Therapies, Gaithersburg, MD 20878, USA. |